Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Matter Bio Logo
Matter Bio Growth Score
47
CB Rank
28764
Heat Score
32
Matter Bio operates as company focus on preserving genome integrity.
Founded
obfuscation
PrivateGrant New York, New York, United States1-10 matterbio.com/
Biotechnology
Life Science
Overview

Matter Bio
Total Funding
obfuscation
Growth Score
47
Heat Score
32

Total Funding
obfuscation
Grant raised
obfuscation
Growth Score47
-8 pts
in past quarter
Heat Score 32
18 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Matter Bio

CB Rank
28764
Matter Bio operates as company focus on preserving genome integrity.
Founded
obfuscation
PrivateGrant New York, New York, United States1-10 matterbio.com/
Biotechnology
Life Science

Funding Rounds

Grant
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Details

Operating Status Active
Company Type For Profit
About the Company
Matter Bio operates as company focus on preserving genome integrity.
Predictions & Insights

Products & Services

Spellcheck Bio
A DNA editing technology that detects somatic mutations before correcting them, editing only when necessary.
Loki Therapeutics
An immune therapy platform using engineered Listeria bacteria to selectively infect and destroy tumor cells by reactivating memory T-cells.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Matter Bio Logo
Grant - Matter Bio
3
obfuscation
— Grant
obfuscation
Grant - Matter Bio Logo
Grant - Matter Bio
3
obfuscation
— Grant
obfuscation
Grant - Matter Bio Logo
Grant - Matter Bio
3
obfuscation
— Grant
obfuscation
Grant - Matter Bio Logo
Grant - Matter Bio
3
obfuscation
— Grant
obfuscation
Grant - Matter Bio Logo
Grant - Matter Bio
3
obfuscation
— Grant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Matter Bio Logo
Grant - Matter Bio
3
obfuscation
— Grant
obfuscation
Grant - Matter Bio Logo
Grant - Matter Bio
3
obfuscation
— Grant
obfuscation
Grant - Matter Bio Logo
Grant - Matter Bio
3
obfuscation
— Grant
obfuscation
Grant - Matter Bio Logo
Grant - Matter Bio
3
obfuscation
— Grant
obfuscation
Grant - Matter Bio Logo
Grant - Matter Bio
3
obfuscation
— Grant

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Contacts 1
News

News and Press

News•May 20, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 19, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 24, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 23, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$489.3KThis year, Matter Bio is projected to spend $489.3K on IT, according to Aberdeen.

Active Website Tech Count

5Matter Bio is actively using 5 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  reCAPTCHA.
Sub-Organizations
Frequently Asked Questions

Where is Matter Bio's headquarters? Matter Bio is located in New York, New York, United States.Who invested in Matter Bio? Matter Bio has 5 investors including National Institute of Environmental Health Sciences and  National Cancer Institute.When was the last funding round for Matter Bio? Matter Bio closed its last funding round on
obfuscation
from a Grant round.Who are Matter Bio's competitors? Alternatives and possible competitors to Matter Bio may include BioAge Labs, Altos Labs, and  Cambrian Biopharma.How much funding has Matter Bio raised to date? Matter Bio has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|